메뉴 건너뛰기




Volumn 12, Issue 4, 2014, Pages 118-120

Obinutuzumab for previously untreated chronic lymphocytic leukemia

(1)  Stenger, Matt a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENDAMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; FLUDARABINE; IBRUTINIB; OBINUTUZUMAB; RITUXIMAB;

EID: 84988529975     PISSN: 23307749     EISSN: None     Source Type: Journal    
DOI: 10.12788/jcso.0032     Document Type: Article
Times cited : (2)

References (3)
  • 1
    • 84988455853 scopus 로고    scopus 로고
    • US FDA, Approved drugs, Gazyva (obinutuzumab) Accessed March 18, 2014
    • US FDA. Approved drugs. Gazyva (obinutuzumab). http://www.fda. gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm373263.htm. Accessed March 18, 2014.
  • 3
    • 84894552888 scopus 로고    scopus 로고
    • Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions
    • [Published online January 8 2014] . Accessed March 18 2014
    • Goede V, Fischer K, Busch R, et al. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions [published online January 8, 2014]. N Engl J Med. http://www.nejm.org/doi/full/10.1056/NEJMoa1313984#t=articleTop. doi: 10.1056/NEJMoa1313984. Accessed March 18, 2014.
    • N Engl J Med
    • Goede, V.1    Fischer, K.2    Busch, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.